NCT01216553

Brief Summary

The aim of the study was to investigate the utility and safety of home management of home oxygen therapy in acute bronchiolitis. A matched case-control study, of one hundred and thirty five infants aged less than 12 months diagnosed bronchiolitis with hypoxia attending a pediatric community clinic will be randomly assigned to receive oxygen with or without standard nebulized therapy. Nebulized treatment with either 0.1% epinephrine diluted in bromhexine, or 3% hypertonic saline. Intermittent oxygen treatment will be administered 6 times daily for 7 days. Primary outcome measures will be emergency department visits/hospitalization secondary outcome measures will be changes in Bronchiolitis Caregiver Diary Score.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
135

participants targeted

Target at P50-P75 for phase_4

Timeline
Completed

Started Oct 2011

Typical duration for phase_4

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 6, 2010

Completed
1 day until next milestone

First Posted

Study publicly available on registry

October 7, 2010

Completed
12 months until next milestone

Study Start

First participant enrolled

October 1, 2011

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2013

Completed
1.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2014

Completed
Last Updated

July 12, 2011

Status Verified

July 1, 2011

Enrollment Period

1.6 years

First QC Date

October 6, 2010

Last Update Submit

July 10, 2011

Conditions

Keywords

BronchiolitisInfantsNebulized InhalationRSVOxygen

Outcome Measures

Primary Outcomes (1)

  • Home oxygen therapy in the ambulatory treatment of bronchiolitis

    Primary outcome measures of the study will be the number of emergency room visits or hospitalizations within two weeks of enrollment in the study.

    1 month

Secondary Outcomes (2)

  • Home oxygen therapy in the ambulatory treatment of bronchiolitis

    1 month

  • daycare(patients) and work (parents) lost because of the illness.

    1 month

Study Arms (2)

hypertonic inhalation + O2

ACTIVE COMPARATOR

oxygen for 30 minuets after inhalation of 3% saline 4 times daily

Other: Oxygen Therapy

Epinephrine & bromhexine nebulized + O2

ACTIVE COMPARATOR

oxygen for 30 minuets after inhalation of racemic epinephrine with bromhexine 4 times daily

Other: Oxygen Therapy

Interventions

1 lt/min oxygen via nasal cannulae intermittently for 30 minuets 4 times daily for 7 days

Also known as: O2
Epinephrine & bromhexine nebulized + O2hypertonic inhalation + O2

Eligibility Criteria

Age8 Weeks - 24 Months
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Infants, aged less than 24 months treated for acute viral bronchiolitis in a pediatric ambulatory clinic in central Israel, during the winter season (December through April) of 2011-2013. The clinical diagnosis will be based on findings of a first clinical bronchiolitis requiring oxygen for hypoxia.

You may not qualify if:

  • Infants with chronic diseases, such cardiorespiratory disease, cystic fibrosis or neonatal asthma, malignancy or immunodeficiency will be excluded, as will be infants in severe distress (respiratory rate \>80breaths/min, heart rate \>200beats/min, BCD score \>13, SpO2). Infants who had recovered from chronic neonatal lung disease of prematurity will be included. In addition, we will excluded infants who had received corticosteroids or bronchodilators in any form within 14 days before presentation and infants whose parents refused to participate or were unable to complete the Bronchiolitis Caregiver Diary Score.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Gani- Hdar Clinic

Petah Tikva, Israel

Location

Clalit health services -Gani Hadar Clinic

Tel Aviv, Israel

Location

MeSH Terms

Conditions

Bronchiolitis

Interventions

Oxygen

Condition Hierarchy (Ancestors)

BronchitisRespiratory Tract InfectionsInfectionsBronchial DiseasesRespiratory Tract DiseasesLung Diseases, ObstructiveLung Diseases

Intervention Hierarchy (Ancestors)

ChalcogensElementsInorganic ChemicalsGases

Central Study Contacts

E. Michael sarrell, MD

CONTACT

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

October 6, 2010

First Posted

October 7, 2010

Study Start

October 1, 2011

Primary Completion

May 1, 2013

Study Completion

August 1, 2014

Last Updated

July 12, 2011

Record last verified: 2011-07

Locations